Gene · 90
Papers2,859
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,859
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cell Senescence in Heterotopic Ossification. | Biomolecules | 2024 | 38672501 | PubTator, text mining | PubMed |
| Inhibition of YAP/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells. | Cell Signal | 2024 | 38643945 | PubTator, text mining | PubMed |
| Momelotinib in myelofibrosis. | Expert Opin Pharmacother | 2024 | 38623844 | PubTator, text mining | PubMed |
| Fibrodysplasia Ossificans Progressiva: A Case Report. | Cureus | 2024 | 38576636 | PubTator, text mining | PubMed |
| BRCC3 Regulation of ALK2 in Vascular Smooth Muscle Cells: Implication in Pulmonary Hypertension. | Circulation | 2024 | 38557054 | PubTator, text mining | PubMed |
| Intersections of Fibrodysplasia Ossificans Progressiva and Traumatic Heterotopic Ossification. | Biomolecules | 2024 | 38540768 | PubTator, text mining | PubMed |
| Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial. | Leuk Lymphoma | 2024 | 38501751 | PubTator, text mining | PubMed |
| iMSC-mediated delivery of ACVR2B-Fc fusion protein reduces heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva. | Stem Cell Res Ther | 2024 | 38500216 | PubTator, text mining | PubMed |
| Discovery of Conformationally Constrained ALK2 Inhibitors. | J Med Chem | 2024 | 38498998 | PubTator, text mining | PubMed |
| Hematology: the specialty with a record number of new approvals. | Front Med (Lausanne) | 2024 | 38487026 | PubTator, text mining | PubMed |
| The prognostic value and potential immunotherapeutic efficacy of ACVR1 in treating gastric cancer. | J Gastrointest Oncol | 2024 | 38482233 | PubTator, text mining | PubMed |
| A BMP-controlled metabolic/epigenetic signaling cascade directs midfacial morphogenesis. | J Clin Invest | 2024 | 38466355 | PubTator, text mining | PubMed |
| Role of the NF-kB signalling pathway in heterotopic ossification: biological and therapeutic significance. | Cell Commun Signal | 2024 | 38439078 | PubTator, text mining | PubMed |
| Inhibition of ALK3-mediated signalling pathway protects against acetaminophen-induced liver injury. | Redox Biol | 2024 | 38401290 | PubTator, text mining | PubMed |
| Oxidative phosphorylation is a pivotal therapeutic target of fibrodysplasia ossificans progressiva. | Life Sci Alliance | 2024 | 38365425 | PubTator, text mining | PubMed |
| Efficacy, safety, and survival findings after long-term follow-up of ZGJAK002: A phase 2 study comparing jaktinib at 100 mg twice daily (BID) and 200 mg once daily (QD) in patients with myelofibrosis. | Am J Hematol | 2024 | 38343062 | PubTator, text mining | PubMed |
| The Activation of the Fibrodysplasia Ossificans Progressiva-Inducing ALK2-R206H Mutant Depends on the Distinct Homo-Oligomerization Patterns of ACVR2B and ACVR2A. | Cells | 2024 | 38334613 | PubTator, text mining | PubMed |
| Anemia-related response end points in myelofibrosis clinical trials: current trends and need for renewed consensus. | Future Oncol | 2024 | 38318719 | PubTator, text mining | PubMed |
| Novel insights on genetics and epigenetics as clinical targets for paediatric astrocytoma. | Clin Transl Med | 2024 | 38299304 | PubTator, text mining | PubMed |
| Editorial: New insights into investigating schizophrenia as a disorder of molecular pathways. | Front Mol Neurosci | 2024 | 38274843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/90/papers?page=8